3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Lymphoid
156
Breast
48
Sarcoma
44
Other hematologic neoplasm
43
Gynecologic
27
Genitourinary
15
Gastrointestinal
13
CNS
12
Plasma cell
9
Other solid neoplasm
7
Thoracic
5
Myeloid
3
Dermatologic
3
Tumor-Agnostic
2
Interventions
lutetium Lu 177 dotatate
29
Magnetic Resonance Spectroscopy
15
Everolimus
10
pembrolizumab
9
Specimen Handling
9
cabozantinib
7
Nivolumab
7
Lutetium-177
6
surufatinib
5
lenvatinib
5
Octreotide
5
Capecitabine
5
177Lu-octreotide, DOTA(0)-Tyr(3)-
5
olaparib
4
lanreotide
4
gallium Ga 68 dotatate
4
amino-acid, glucose, and electrolyte solution
4
X-Rays
4
Lutetium
4
Ipilimumab
4
Injections
4
Fluorodeoxyglucose F18
4
copper dotatate CU-64
3
atezolizumab
3
Temozolomide
3
Ga(III)-DOTATOC
3
Cyclophosphamide
3
Carboplatin
3
pasireotide
2
fludarabine phosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Doxorubicin
×
NET
×
1 year
×
Clear all
No trials found.